Keyphrases
Hematological Malignancies
100%
Dendritic Cells
100%
CD34+ Stem Cells
100%
Anti-tumor Response
100%
MHC Class II
50%
Genetic Modification
25%
Clinical Trials
25%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
25%
T Cells
25%
T Cell Activation
25%
Antigen Presentation
25%
DC Subsets
25%
Long-term Efficacy
25%
Tumor Immunology
25%
Gene Modification
25%
Immunosuppression
25%
DC Vaccination
25%
DC Vaccine
25%
Immunological Response
25%
Hematopoietic Progenitor Cell Transplantation
25%
DC Migration
25%
Control Potential
25%
Cross-presentation
25%
Response Control
25%
Costimulation
25%
DC Maturation
25%
Medicine and Dentistry
Neoplasm
100%
Dendritic Cell
100%
Hematologic Malignancy
100%
Hematopoietic Cell
100%
Maturation
33%
Major Histocompatibility Complex
33%
Immunosuppressive Treatment
33%
Clinical Trial
16%
T Cell
16%
Cell Transplantation
16%
Cross Presentation
16%
T Cell Activation
16%
Co-Stimulation
16%
Antigen Presentation
16%
Immunology and Microbiology
Hematopoietic Cell
100%
Dendritic Cell
100%
Maturation
33%
CD34
33%
Major Histocompatibility Complex
33%
Immunosuppression
33%
T Cell
16%
T Cell Activation
16%
Cell Transplantation
16%
Antigen Presentation
16%
Co-Stimulation
16%
Cross-Presentation
16%
Biochemistry, Genetics and Molecular Biology
Dendritic Cell
100%
Hematopoietic Cell
100%
T Cell
33%
Maturation
33%
CD34
33%
Major Histocompatibility Complex
33%
Clinical Trial
16%
Cell Transplantation
16%
Cell Activation
16%
Antigen Presentation
16%
Cross Presentation
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Hematologic Malignancy
100%
Clinical Trial
25%